Detection of paracetamol binding to albumin in blood serum using 2D-IR spectroscopy.


Journal

The Analyst
ISSN: 1364-5528
Titre abrégé: Analyst
Pays: England
ID NLM: 0372652

Informations de publication

Date de publication:
22 Jul 2022
Historique:
pubmed: 15 7 2022
medline: 27 7 2022
entrez: 14 7 2022
Statut: epublish

Résumé

Binding of drugs to blood serum proteins can influence both therapeutic efficacy and toxicity. The ability to measure the concentrations of protein-bound drug molecules quickly and with limited sample preparation could therefore have considerable benefits in biomedical and pharmaceutical applications. Vibrational spectroscopies provide data quickly but are hampered by complex, overlapping protein amide I band profiles and water absorption. Here, we show that two-dimensional infrared (2D-IR) spectroscopy can achieve rapid detection and quantification of paracetamol binding to serum albumin in blood serum at physiologically-relevant levels with no additional sample processing. By measuring changes to the amide I band of serum albumin caused by structural and dynamic impacts of paracetamol binding we show that drug concentrations as low as 7 μM can be detected and that the availability of albumin for paracetamol binding is less than 20% in serum samples, allowing identification of paracetamol levels consistent with a patient overdose.

Identifiants

pubmed: 35833538
doi: 10.1039/d2an00978a
doi:

Substances chimiques

Amides 0
Blood Proteins 0
Serum Albumin 0
Acetaminophen 362O9ITL9D

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3464-3469

Auteurs

Samantha H Rutherford (SH)

WestCHEM, Department of Pure and Applied Chemistry, University of Strathclyde, Technology and Innovation Centre, 99 George Street, Glasgow, G1 1RD, UK. samantha.hume-rutherford@strath.ac.uk.

Gregory M Greetham (GM)

STFC Central Laser Facility, Research Complex at Harwell, Rutherford Appleton Laboratory, Harwell Campus, Didcot, OX11 0QX, UK.

Michael Towrie (M)

STFC Central Laser Facility, Research Complex at Harwell, Rutherford Appleton Laboratory, Harwell Campus, Didcot, OX11 0QX, UK.

Anthony W Parker (AW)

STFC Central Laser Facility, Research Complex at Harwell, Rutherford Appleton Laboratory, Harwell Campus, Didcot, OX11 0QX, UK.

Soheila Kharratian (S)

Department of Chemistry and York Biomedical Institute, University of York, Heslington, York, YO10 5DD, UK.
School of Physics, Engineering and Technology and York Biomedical Research Institute, University of York, Heslington, York, YO10 5DD, UK.

Thomas F Krauss (TF)

School of Physics, Engineering and Technology and York Biomedical Research Institute, University of York, Heslington, York, YO10 5DD, UK.

Alison Nordon (A)

WestCHEM, Department of Pure and Applied Chemistry and CPACT, University of Strathclyde, 295 Cathedral Street, Glasgow, G1 1XL, UK.

Matthew J Baker (MJ)

WestCHEM, Department of Pure and Applied Chemistry, University of Strathclyde, Technology and Innovation Centre, 99 George Street, Glasgow, G1 1RD, UK. samantha.hume-rutherford@strath.ac.uk.
Dxcover Ltd, Suite RC534, 204 George Street, Glasgow, G1 1XL, UK.

Neil T Hunt (NT)

Department of Chemistry and York Biomedical Institute, University of York, Heslington, York, YO10 5DD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH